EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:752926 - reslizumab
| ChEBI ID | CHEBI:752926 |
| ChEBI Name | reslizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | anti-asthmatic agent Any compound that has anti-asthmatic effects. antiparasitic agent A substance used to treat or prevent parasitic infections. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| reslizumab (CHEBI:752926) has role anti-asthmatic agent (CHEBI:65023) |
| reslizumab (CHEBI:752926) has role antiparasitic agent (CHEBI:35442) |
| reslizumab (CHEBI:752926) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| CEP-38072 | ChEMBL |
| DCP 835 | ChEMBL |
| DCP-835 | ChEMBL |
| Reslizumab | ChEMBL |
| SCH 55700 | ChEMBL |
| SCH-55700 | ChEMBL |
| Brand Names | Source |
|---|---|
| Cinqaero | ChEMBL |
| Cinqair | ChEMBL |
| Cinquil | ChEMBL |